Clyra is a company within the Healthcare category. Clyra Medical Technologies is a medical device company that develops and commercializes advanced wound care products. The company's technology utilizes a proprietary copper-iodine formula designed to safely and effectively eliminate biofilms and pathogens without toxicity to healthy tissue.
Clyra was founded in 2012 and is headquartered in Westminster, CA.
Clyra is rated Emerging on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Clyra is Moderate. Significant factual deltas detected.
AI models classify Clyra as a Challenger. AI names competitors first.
Clyra appeared in 4 of 8 sampled buyer-intent queries (50%). Clyra is highly discoverable for technical queries (copper-iodine wound care) but loses share in broader queries (best antimicrobial wound wash) to large incumbents like Smith & Nephew.
Clyra is perceived as a specialized biotech innovator in the wound care space. While its technical efficacy is recognized, its corporate scale and market reach are often underestimated or omitted. Key gap: The specific distinction between 'Clyra Medical' (the company) and 'Clyra' (the product brand) is often blurred, leading to confusion about its independent corporate status vs. its parent company.
Of 5 key facts verified about Clyra, 3 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 1 are retrieval-dependent and may be inaccurate without live search.
Company size and private financial details (revenue, exact employee count) are highly speculative in AI models due to its status as a subsidiary.
Buyers turn to Clyra for Standard Antiseptics: Hospitals and clinics using standard povidone-iodine or chlorhexidine gluconate solutions for wound cleansing., Saline Irrigation: Using sterile saline or tap water to irrigate wounds without specialized antimicrobial agents., Status Quo Protocols: Maintaining existing wound care protocols without integrating advanced copper-iodine technology., among 3 documented problem areas.
Buyers evaluating Clyra typically ask AI models about "copper iodine wound care technology", "best hospital wound irrigation solutions", "FDA cleared biofilm treatment for chronic wounds", and 1 similar queries.
Clyra's core products are Clyra Wound Gel, Clyra Sisidue Wound Wash.
Clyra uses Enterprise/Custom (Hospital/Clinical Pricing).
Clyra serves Hospitals, Chronic Wound Care Centers, Surgical Centers, Long-term Care Facilities.
Clyra Proprietary copper-iodine technology that is highly effective against biofilms while remaining non-toxic to healthy tissue.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/clyra
Last analyzed: April 11, 2026
Founded: 2012
Headquarters: Westminster, California